Question

Difficulty: HardPreventive Care and Screening

A 54-year-old man presents to the clinic to establish primary care after recently relocating. He feels well, has no current symptoms, and has not been evaluated by a physician in five years. His medical history is significant for essential hypertension, which is well-controlled on amlodipine. His social history is notable for having smoked 1 pack of cigarettes daily from age 20 until he quit at age 42. He consumes alcohol occasionally. His family history is notable for a father diagnosed with prostate cancer at age 70. Preventive care history reveals that he underwent a screening colonoscopy 9 years ago at age 45, which was completely normal. He received a Tdap booster 5 years ago but has no record of receiving any other adult vaccinations. Physical examination reveals a blood pressure of 126/78 mmHg, heart rate of 72/min, and a BMI of 26 kg/m². The remainder of the examination is unremarkable.

Which of the following preventive interventions are indicated for this patient today? (Select all that apply)

  1. 20-valent pneumococcal conjugate vaccine (PCV20)Answer
  2. Annual low-dose computed tomography (LDCT) of the chestAnswer
  3. C
    Screening colonoscopy
  4. D
    One-time abdominal aortic aneurysm screening ultrasound
  5. E
    Routine screening electrocardiogram

Answer

The indicated interventions are the 20-valent pneumococcal conjugate vaccine (PCV20) and annual low-dose computed tomography (LDCT) of the chest.
The correct interventions are LDCT and PCV20. Annual LDCT of the chest is recommended by the USPSTF for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This patient is 54, has a 22 pack-year history, and quit 12 years ago, fully meeting the criteria. Furthermore, based on current ACIP guidelines, routine pneumococcal vaccination (e.g., PCV20) is now recommended for all adults aged 50 years and older, regardless of underlying medical conditions. Because this patient is 54 and has no record of prior pneumococcal vaccination, it is indicated today.

Step-by-Step Solution

1
Calculate the patient's smoking pack-years and years since quitting.
The patient smoked 1 pack/day for 22 years (age 20 to 42), totaling 22 pack-years. He is currently 54 and quit at 42, meaning he quit 12 years ago.
Lung cancer screening criteria rely heavily on exact pack-years and the time elapsed since smoking cessation.
2
Evaluate eligibility for lung cancer screening based on current USPSTF guidelines.
LDCT is indicated because the patient falls within the 50-80 age range, has a ≥20 pack-year history, and quit within the last 15 years.
Failing to recognize that the patient is still within the 15-year window since quitting is a common diagnostic oversight.
3
Assess the patient's immunization requirements based on updated ACIP schedules.
PCV20 is indicated because the Advisory Committee on Immunization Practices (ACIP) updated its guidelines to recommend routine pneumococcal vaccination for all adults aged 50 and older.
Keeping up-to-date with recent age-threshold changes for immunizations is critical for effective preventive care.
4
Review the remaining options against specific age and interval guidelines.
Colonoscopy is excluded (due at year 10; currently at year 9). AAA ultrasound is excluded (starts at age 65). ECG is excluded (Grade D recommendation for asymptomatic low-risk adults).
Prevents overutilization of screening modalities and adheres strictly to evidence-based intervals.

Key Concept

Age and risk-based application of preventive screening and immunization guidelines.
Rate this question